Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume creates decreases

.After raising $213 million in 2023-- some of the year's biggest private biotech shots-- Tome Biosci...

BioMarin develops director group along with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings...

Biopharma Q2 VC attacked highest degree considering that '22, while M&ampA decreased

.Equity capital backing into biopharma cheered $9.2 billion around 215 sell the 2nd fourth of this y...

Bicara, Zenas look for IPOs to push late-phase assets towards market

.Bicara Rehabs and Zenas Biopharma have given new motivation to the IPO market along with filings th...

Genentech to close cancer immunology research study team

.Genentech will definitely shut its own cancer cells immunology investigation division, and unit hea...

Kezar falls sound tumor however to confirm its own well worth in phase 1 test

.Kezar Lifestyle Sciences is actually losing its dim stage 1 solid lump medication as the biotech go...

Acelyrin drops izokibep, drops 3rd of workers

.Despite izokibep sustaining its newfound winning streak in the clinic, Acelyrin is actually no long...

Rivus' period 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid stops preclinical job, IV system after soticlestat stop working

.Ovid Rehab currently exposed final month that it was actually trimming its headcount as the provide...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston ma Seaport, enhancing its RNA as...